• Science and Research

  Long-term Treatment with Kalydeco Reduces Risk of CF Lung Infection, Study Reports

  Posted by cystic-fibrosis-news-moderator on August 8, 2019 at 9:11 am

  

  Treatment for three years with the approved therapy Kalydeco reduces the risk of serious lung infection in cystic fibrosis, a UK study reports. Read more about it here.

  What do you think of this news?

  cystic-fibrosis-news-moderator replied 4 years, 8 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply